361
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide

ORCID Icon, , &
Pages 2973-2983 | Published online: 29 Apr 2019

References

  • Cho H, Gao J, Kwon G. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery. J Control Release. 2016;240:191–201. doi:10.1016/j.jconrel.2015.12.01526699425
  • Cho H, Jammalamadaka U, Tappa K. Nanogels for pharmaceutical and biomedical applications and their fabrication using 3D printing technologies. Materials. 2018;11(2):302. doi:10.3390/ma11081451
  • Elkomy M, Elmenshawe S, Eid H, Ali AMA. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling. Drug Deliv. 2016;23(9):3294–3306. doi:10.1080/10717544.2016.117608627066917
  • Neamtu I, Rusu A, Diaconu A, Nita L, Chiriac A. Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Deliv. 2017;24(1):539–557. doi:10.1080/10717544.2016.127623228181831
  • Sushil K, Arun KI. Biodegradable topical nanogels in the treatment of skin and superficial tumors. Glob J Nano. 2017;1(2):555–556.
  • Kakkar S, Kaur I. Spanlastics—a novel nanovesicular carrier system for ocular delivery. Int J Pharm. 2011;413(1–2):202–210. doi:10.1016/j.ijpharm.2011.04.02721540093
  • Li R, Jiang S, Liu D, et al. A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide. J Microencapsul. 2011;28(2):134–141. doi:10.3109/02652048.2010.53930421142697
  • Modi K, Shelat PK. Applications of novel vesicular drug delivery system as ocular drug vehicles: a review. Ijpsr. 2012;3(12):4554–4561.
  • Parthibarajan R, Gowrishankar N, Prashanth D, Mallikarjun RV. Formulation and in-vitro evaluation of floating microspheres of acetazolamide. Int J Pharm Pharm Sci. 2011;5(1):447–453.
  • Granero G, Maitre M, Garnero C, Longhi M. Synthesis, characterization and in vitro release studies of a new acetazolamide–HP-β-CD–TEA inclusion complex. Eur J Med Chem. 2008;43(3):464–470. doi:10.1016/j.ejmech.2007.03.03717544174
  • Manchanda S, Sahoo P. Topical delivery of acetazolamide by encapsulating in mucoadhesive nanoparticles. Asian J Pharm Sci. 2017;12(6):550–557. doi:10.1016/j.ajps.2017.04.005
  • Kumar G, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1(4):208–219. doi:10.1016/j.apsb.2011.09.002
  • Abraham S, Furtado S, Bharath S, Basavaraj B, Deveswaran R, Madhavan V. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Pak J Pharm. Sci. 2009;22:2.
  • Basha M, Abd El-Alim S, Shamma R, Awad G. Design and optimization of surfactant-based nanovesicles for ocular delivery of clotrimazole. J Liposome Res. 2013;23(3):203–210. doi:10.3109/08982104.2013.78802523607316
  • ElMeshad A, Mohsen A. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. 2016;23(7):2115–2123. doi:10.3109/10717544.2014.94281125080226
  • Salem H, Ahmed S, Omar M. Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery. Drug Des Devel Ther. 2016;10:277. doi:10.2147/DDDT.S91730
  • Elazreg R, Soliman M, Mansour S, El Shamy A. Preparation and evaluation of mucoadhesive gellan gum in-situ gels for the ocular delivery of carbonic anhydrase inhibitor nanovesicles. Ijpsr. 2015;6(9):3761–3774.
  • Gheran C, Rigaux G, Callewaert M, et al. Biocompatibility of Gd-loaded chitosan-hyaluronic acid nanogels as contrast agents for magnetic resonance cancer imaging. Nanomaterials. 2018;8(4):201. doi:10.3390/nano8040201
  • Callewaert M, Roullin V, Cadiou C, et al. Tuning the composition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T 1/T 2 MRI contrast agents. J Mat Chem B. 2014;2(37):6397–6405. doi:10.1039/C4TB00783B
  • El-Menshawe SF, Kharshom R, El Sisi A. Preparation and optimization of buccal propranolol hydrochloride nanoethosomal gel: a novel approach for enhancement of bioavailability. J Nanomed Nanotechnol. 2017;8(2):1000435.
  • Başaran E, Yazan Y. Ocular application of chitosan. Expert Opin Drug Deliv. 2012;9(6):701–712. doi:10.1517/17425247.2012.68177522530690
  • El-Leithy E, Shaker D, Ghorab M, Abdel-Rashid R. Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium–chitosan microspheres for rectal administration. AAPS PharmSciTech. 2010;11(4):1695–1702. doi:10.1208/s12249-010-9544-321108027
  • El-Samaligy M, Yahia S, Basalious E. Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm. 2004;286(1–2):27–39. doi:10.1016/j.ijpharm.2004.07.03315501000
  • Omar MM, Hassan OA, Elsisi AM. Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation. Int J Nanomed. 2019;14:1551–1562. doi:10.2147/IJN.S201356
  • Hassan D, Abdelmonem R, Abdellatif M. Formulation and characterization of carvedilol leciplex for glaucoma treatment: in-vitro, ex-vivo and in-vivo study. Pharmaceutics. 2012;10(4):197. doi:10.3390/pharmaceutics10040197
  • Bancroft J, Stevens A. Theory and Practice of Histological Techniques. 4th ed. Edinburgh: Churchill Livingstone; 1990.
  • Piplani P, Kumar P, Rohilla A, Singla S, Kaur I. Development and evaluation of an ocular niosomal delivery system for some newly synthesized Beta blockers. Ajbps. 2015;5(40):8. doi:10.15272/ajbps.v4i40.634
  • Abdelkader H, Alani AW, Alany R. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21(2):87–100. doi:10.3109/10717544.2013.83807724156390
  • Van Den Bergh BA, Wertz P, Junginger H, Bouwstra J. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm. 2001;217(1–2):13–24.11292538
  • Souto E, Müller R. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006;23(4):377–388. doi:10.1080/0265204050043529516854814
  • Manosroi A, Khanrin P, Werner R, Götz F, Manosroi W, Manosroi J. Entrapment enhancement of peptide drugs in niosomes. J Microencapsul. 2010;27(3):272–280. doi:10.3109/0265204090313129320113169
  • Lee E, Kim A, Oh Y-K, Kim C. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials. 2005;26(2):205–210. doi:10.1016/j.biomaterials.2004.02.02015207467
  • Cho I, Park C, Huh B, et al. Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy. Acta Biomater. 2016;39:124–132. doi:10.1016/j.actbio.2016.05.01127163401
  • Liu L, Gao Q, Lu X, Zhou H. In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration. Asian J Pharm Sci. 2016;11(6):673–683. doi:10.1016/j.ajps.2016.07.001
  • Kalam M, Khan A, Khan S, Almalik A, Alshamsan A. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design. Int. J. Biol. Macromol. 2016;87:329–340. doi:10.1016/j.ijbiomac.2016.02.03326893052
  • Bhumkar D, Pokharkar V. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech. 2006;7(2): E138-E143. doi:10.1208/pt070250
  • Park C, Kim M, Park M, et al. Nanostructured mucoadhesive microparticles for enhanced preocular retention. Acta Biomater. 2014;10(1):77–86. doi:10.1016/j.actbio.2013.08.02623978409
  • Ding D, Kundukad B, Somasundar A, Vijayan S, Khan S, Doyle P. Design of mucoadhesive PLGA microparticles for ocular drug delivery. ACS Appl Bio Mater. 2018;1(3):561–571. doi:10.1021/acsabm.8b00041
  • Kaur I, Rana C, Singh M, Bhushan S, Singh H, Kakkar S. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. J Ocul Pharmacol Ther. 2012;28(5):484–496. doi:10.1089/jop.2011.017622694593
  • Abdelkader H, Ismail S, Kamal A, Alany R. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 2011;100(5):1833–1846. doi:10.1002/jps.2242221246556
  • Rupenthal I, Green C, Alany R. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm. 2011;411(1–2):69–77. doi:10.1016/j.ijpharm.2011.03.04221453762
  • Hathout R, Mansour S, Mortada N, Guinedi A. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2007;8(1):E1–E12. doi:10.1208/pt0801001
  • Tayel S, El-Nabarawi M, Tadros M, Abd-Elsalam W. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013;443(1–2):293–305. doi:10.1016/j.ijpharm.2012.12.04923333217
  • M Ways T, Lau W, Khutoryanskiy V. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers. 2018;10(3):267. doi:10.3390/polym10030267